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Objectives. Tuberculosis treatment and susceptibilrty
testing are cumbersome, especially in the case of
multidrug-resistant (MDR) Mycobacterium tuberculosis. It
is known that mutations in the rpoB gene of M.
tuberculosis lead to resistance to rifampicin (RMP). In this
study, an attempt was made to apply molecular
techniques for rapid detection of antibiotic resistance in
clinical isolates of M. tuberculosis.
Design. settings and subjects. RMP-resistant clinical
isolates of M. tuberculosis from South Africa (N = 120) with
unique resistant patterns were selected for calculation of
resistance frequencies, and 74 MDR isolates of M.
tuberculosis from different geographical origins were used
for microbiological and molecular anaJysis. The
polymerase chain reaction (PeR) technique was applied
for amplification of a previously described region around a
cluster of mutations in the rpaS gene, and single-stranded
conformational polymorphism (SSCP) analysis was
optimised to screen for mutations in the amplified region.
Results. The results showed that an optimised PCR-
SSCP procedure could detect a cluster of mutations in the
rpoB gene (for RMP resistance) in 95% of RMP-resistant
isolates. This procedure could therefore be used in the
prediction of RMP resistance.
Evidence was obtained that these mutations can be
screened for directly from BACTEC cultures or even
directly from Ziehl-Neelsen-positive sputum samples.
Statistical analysis also showed that this locus can be
used to predict the presence of an MDR isolate, which
may have important implications in decisions concerning
chemotherapy.
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Conclusions. It is currently not feasible to test all
tuberculosis cases, but application of the PCR-SSCP
technology in the prediction of multidrug resistance in
M. tuberculosis isolates may be important in patients,
especially where frequencies are high for drug-resistant
isolates. This methodology could reduce the time required
for sensitivity testing from approximately 6 - 12 weeks to a
few days.
S Afr Med J 1996; 86: 50-55.
Tuberculosis treatment regimens including rifampicin (AMP)
and isoniazid (INH) have been complicated by an increasing
frequency of multidrug-resistant (MDR) strains of
Mycobacterium tuberculosis. The prevalence of tuberculosis
before the 1980s, which is considered to be a turning point
in the struggle with the tubercle bacillus, indicated a decline
in the disease.' However, owing to limited understanding of
the disease and poor compliance, a resurgence since the
middle to late 1980s occurred.: Of concern is the emergence
of drug-resistant strains during the last few years, and
efforts have been made to unravel the mechanisms of action
and to understand the molecular basis of resistance to these
antibiotics. Deviations in structural genes encoding target-
proteins may lead to differences in secondary structure of
such proteins, and therefore loss of functionality. These
differences may cause insufficient binding of the antibiotic to
its target, and ultimately lead to antibiotic resistance. It is
generally accepted that the phenotypic outgrowth of the
antibiotic-resistant organisms is the result of selective
pressures caused by the antibiotic.
It is now possible to detect many causative mutations
with the aid of molecular technology. Much of the detection
has been done using a polymerase chain reaction (PCA)-
based technique, single-stranded conformation
poiymorphism (SSCP), to enable the detection of single-
base substitutions, as well as small deletions and/or
insertions.' This technique has been widely applied in the
investigation of drug resistance in tuberculosis as well as in
human genetic diseases.u
It is known from studies on Escherichia coli that RMP is
directed towards the ~-subunilof RNA polymerase,
encoded by the rpoB gene.' Comparison of the primaI)/
structure of the rpoB proteins from several bacteria led to
the identification of six highly conserved regions, including a
cluster near the centre of the rpoB gene. This region is
frequently mutated, and by using PCR-SSCP analysis,
together with nucleotide sequencing analysis, mutations
involving eight conserved amino acids have been identified
in this region in -97% of RMP-resistant isolates of E. coli,
M. smegmatis and M. tuberculosis.&.I These mutations were
all clustered within a 23-amino acid-encoding region of the
rpoB gene, and encode resistance to RMP in M.
tuberculosis.' The same mutations were not found in isolates
suscaptible to RMP.
Susceptibility testing of antibiotics in slow-growing
organisms is cumbersome and requires pure isolates of the
test organism. The aim of this study was to optimise the
SSCP procedure for detection of rpoB gene mutations, and
to use this gene tocus as molecular marker together with
MDR profiles of clinical isolates of M. tuberculosis to assess
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Table I. Characteristics and molecular data of RMP-resistant
clinical isolates
whether this protocol could be used to predict the presence
of a MDA strain of M. tuberculosis in biological samples.
Isolate Resistance pattern
MIC,RMP
r.. lJQImJ,
at 21 days) -
data
mu!
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• No gene deoiaticns.
lNH =ISOniazid; RMP =rifaTlpici'l; ETH =etho"~ EMS =eIhiiIJi:Ju!oI; PZA =
pyramarnide; Kanan = kartarnycWt; Th =~ SM = streptemyein;~ =
cyclosi!rine; MIC = mnmaI inhibitory 0Cll iCEilb iiliJii; I0OI - Iruti'I!im; NA _ no da!a iNi!iIaCIe.
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> '00
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INH, RMP
INH, AMP
INH, AMP
INH, AMp, EMS
INH, AMP, EMS
INH, RMP, EM8
INH, AMP, EMS
INH,Efo..18
South Africa
9213 JNH, AMp, Ern
92/4 INH, RMP, SM
92/5 INH, RMp, SM, ETH, EMS
92/6 INH, AMP, SM
92/7 INH. AMP, SM
93/1 INH. AMp, SM, EMS, PZA
9318 INH, AMp, SM. EMS. PZA
93116 INH. AMp, SM, ETH, EMS. PZA
93/17 INH, AMp, SM. PZA
93/19 INH. AMp, SM
93120 INH, AMp, SM. EMS
93121 INH, AMp, SM, ETH, EM
1131523f92 INH. AMp, SM
1672 INH, AMP, SM
1873 INH, AMp, SM, ETH
1876 tNH, AMP, SM
1893 INH, RMP, SM, ETH. EMS
1964 INH, AMP, EMS
2066 INH, AMP, SM, ETH. EMS
2211 INH, AMP
2364 INH, AMP, SM
TB0019193 INH, AMp, SM, ETH
0150 INH, AMP, SM, ETH
0202 INH, AMp, SM
022.5 INH. RMP, EMS
0249 INH, RMP, EMS
0271 INH, AMP, SM
0287 INH, AMP
0368 INH, AMp, Ern
0416 INH, AMP
0531 INH, AMP, SM
054S INH, AMP, SM, EMS
0547 INH, AMP, SM
0552 INH, AMP, SM
0565 INH, AMp, SM, ETH, EMS
0587 INH, AMp, SM
0651 INH. AMP, SM
0891 INH, AMP
52 INH, AMP
335 INH. AMP, ETH
219 INH, AMP
310 INH, AMP
331 INH, AMP
257 INH, AMP
508 INH, AMP
V10 INH, AMP
V14 AMP
V26 INH, AMp, SM
Vl08 INH, AMp, SM, Kanam, Th
V113 INH, AMP
V117 INH. AMP, SM
Vl22 INH, AMp, SM, Kanam, Th
V134 INH. AMp, Cyclo
V142 INH, AMp, SM, Th
Vl46 INH, AMp, SM, EMS, Cyclo
Ml INH, RMP, SM
M2 INH, AMP
M3 INH, AMp, SM, EMS, Kanam, Th
M4 INH, AMp, Kanam
MS INH, AMP
M6 INH, AMp, SM, EMS, Kanam
M7 INH, AMp, SM, Kanam,
MS lNH, AMP, SM, Kanam, Th
M9 INH, RMP
M10 INH, RMp, SM
Health Department.
Arkansas
1046 lNH, AMP
Health Department.
Texas
11306
113989
113035
113716
113560
Swttzertand
TS173
TBl60
T8149
Co<rtrol
H"Rv
Clinical isolates
The records of 120 AMP-resistant clinical isolates with
unique resistance patterns, determined by culture testing,'
were selected from the database of the National
Tuberculosis Aesearch Programme and used in a statistical
calculation. Cultures and DNA of 74 RMP-resistant strains of
M. tuberculosis with different resistance patterns were used
in this study, for further microbiological and molecular
analysis (Table I).
Minimal inhibitory concentrations (MICs, in jJg/ml) for
rifampicin were determined by the agar dilution method,9 by
incorporating serial twofold dilutions of rifam.picin into
MiddlebrD9k 7H10 agar medium. The inoculates were
prepared from 10-day-old cultures, diluted to a
concentration of approximately 1()ll colony-forming units per
millilitre. Ten microlitres of each culture were then inoculated
(in duplicate) onto the drug-containing and drug-free control
plates, sealed in plastic bags and incubated at 3rC for 21
days. The lowest concentration of the antibiotic inhibiting
growth of more than 99% of the bacterial pcpulation was
considered the MIC.
A scrape of each culture was suspended individually in
-300 ~I of sterile distilled water or saline. Alternatively, DNA
was extracted from some cultures using a standard
protocoL 10 These two different templates were used for PCR
amplification.
Material and methods
peR amplification
Oligonucleotide primers and peR procedure
Primer set TR8fTR9 (TR8 5' TGCACGTCGCGGACCTCCA,
TR9 5' TCGCCGCGATCAAGGAGT) was synthesised by
Genosys, UK, according to the rpaS gene sequence
(GenBank accession number L0591 0), for PCR amplification
of a 157bp fragment of the IpOB gene.
DNA amplification reaction mixtures (per reaction of 95 jJl)
consisted of 1 x Taq buffer, 2.5 mM MgC~, 200 ~M each
dNTP (dATP, dCTP, dGTP and dTTP, respectively), 10 ~M
each of the 5' and 3' oligonucleotide primer and 1.5 U Taq
pclymerase. Rve microlitres of ternplate DNA (-1 ~g) were
inoculated in the reaction mix. Cycling temperatures were as
follows: 93·C for 3 minutes, followed by 35 cycles at 93·C
for 1 minute, saQc for 2 minutes and 72Q C for 2 minutes,
and a final extension cycle at 72°C for 10 minutes. Cycling
was done in a Multigene PCR cycler (MedTech, Cape Town).
Confirmation of PCR amplification was done using 10 ~I
amplified product, electrophoresed on 12% PAGE mini-gels
at 100 V (constant) for 1'12 hours in 1 x mE (10 x mE =
900 mM each Tris and boric acid, and 25 mM EDTA) buffer,
using a BioAad Mini Protean 11 electrophoresis system and
ethidium bromide staining/UV illumination for detection. This
work was carried out in a PCR-equipped laboratory, and
great care was taken to avoid false results due to
contamination of amplified fragments.ll
Mutation analysis
A standard protocol, previously described for mutational
analysis by SSGp, was used innially.' Equal volumes of PGR
product (1 0 ~I each) and stop solution (containing 95%
fomnamide, 20 mM EOTA, and 0.005% each of bromophenol
blue and xylenecyanol FF) were mixed and heat-denatured
at 95°C for 10 minutes, after which the mix was snap-cooled
on ice prior to loading onto the gel.
Optimisation of the SSCP technique for detection of rpaB
mutations was done with 20 isolates (isolates TB1523/92 to
TB0546/93, Table J). Different combinations of parameters
were used in the mutational analysis of the amplified
denatured PGR products. The SSGP gels (1 mm in
thickness) consisted of 6% polyacrylamide (a stock of 30%
acrylannide was used, containing 29% acrylannide and 1%
N'N' methylene bis-acrylamide), 0.6 x TBE buffer and 5% or
0% glycerol, respectively, polymerised wrth 4.2 ml 3%
ammoniumpersulphate and 10% TEMED in a total volume of
200 ml. FMG Gelbond iso-electric focusing film was used to
assist in the handling of the gels. The gels were
electrophoresed in 0.6 x TBE buffer at 50 W or 25 W
(constant power) at room temperature, with cooling from a
bench-top fan, or at OOG for 4 - 5 hours respectively. After
electrophoresis. the gels were disassembled, and fixed for
10 minutes in a buffer containing 10% ethanol and 0.05%
acetic acid. The gels were subsequently placed in a 0.1 %
silver nitrate buffer for 10 minutes.
After washing twice in distilled water, staining was done
on a horizontal orbital shaker in a buffer containing 0.1 M
sodium hydroxide, 1.5M sodium borohydrate and 0.004%
formaldehyde for 20 minutes (or until the bands were
visible). Final fixing of the bands was done in a 0.75%
sodium carbonate buffer for 10 minutes.
Preparation of BACTEC cultures and
sputum samples for mutational
screening
A scrape of isolate TB0287193, resistant to RMP and INH
and containing a mutation in the rpoB gene (fable I), was'
suspended in 200 ~I of phosphate-buffered saline (PBS).
Different ratios of the isolate and the control strain, H37Rv,
were inoculated into BACTEG medium (Table 11). Growth
indices (Gls) were read at 24-hourly intervals on days 0, 1, 2
Ta~le 11. ~ACTEC procedure for detection of mutations - PCR amplification and SSCP analysis after 24·hourly growth periods of RMP-
resistant Isolate T80287/93, with HnRv as control, in BACTEC medium
Sample Isolate
Sample contents of
BACTEG bottle Oay Growth index PGR result SSGP resu~
2
3a
b
c
d
e
H"Rv
TB0287193
50 IJI both isolate
and saline
50 IJI both isolate
and saline
50 ~I both isolates
(1 :1)
(2:1)
(4:1)
(8:1)
(16:1)
o
1
2
3
4
o
1
2
3
4
o
1
2
3
4
o
1
2
3
4
o
1
2
3
4
o
1
2
3
4
o
1
2
3
4
36 NO
123 Pas.
280 NO NO
622 NO NO
;:i!=999 NO NO
9 NO
20 Pas. Pas.
35 NO NO
68 NO NO
135 NO NO
69 NO
241 Pas. Pas.
453 NO NO
799 NO NO
'" 999 NO NO
81 NO
288 Pos. Pas.
668 NO NO
;:i!=999 NO NO
NO NO NO
56 NO
211 Pas. Pos.
461 NO NO
916 NO NO
;:i!=999 NO NO
14 NO
39 Pos. Pas.
89 NO NO
237 NO NO
596 NO NO
19 NO
50 Pas. Pas.
98 NO NO
264 NO NO
587 NO NO
- z no alipif..:::aDOll; Pas. " posltIVe resuJt ND " not done.
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and 3 respectively, using a BACTEC apparatus (Becton-
Dickenson, BACTEC 460, Johnston Laboratories, Md, USA)
after incubation at 3loe, or until Gls exceeded a reading of
999. After measurement of Gls, 200 ~I volumes were
removed from each SACTEC culture, and used for PCA-
SSe? analysis. Five microlitres of each were inoculated in
respective PCA amplification tubes prior to analysis.
Inhibitors of PCA-reactions in four Ziehl-Neelsen (ZN)-
positive sputum samples were removed by a sucrose
procedure,I2 and the reSUlting pellets were used directly for
PCA amplification of a 204bp fragment of the katG gene.
Amplification of this gene segment was used as a model,
and the PCA procedure was the same as described
previously.' Purified DNA from M. tuberculosis strain H~Rv
was used as control.
Results
Detection of mutations in the rpoB
gene
Pure cu~ures, or ahernatively DNA, of M. tuberculosis
isolates resistant to AMP [Table I) were used for PCA
amplification of rpoB, and SUbsequently SSCP anaiysis was
done for mutational screening. Different combinations of
conditions were investigated to optimise the SSCP
procedure for detection of mutations. Using a 'standard set'
of conditions, inclUding 5% glycerol in the 6% SSCP gels
and electrophoresis performed at 50 W for 4 - 5 hours at
room temperature, we were able to detect mutations in the
rpoB genes of 70% of the isolates. Rg. 1 is a sample resutt.
Since a higher incidence of mutations was expected for thiS
gene locus, different electrophoretic conditions were
subsequently evaluated for isolates TB1523192 to .
TB0546193 [Table Q. These conditions included gels without
glycerol, different percentages of glycerol and
electrophoresis at different temperatures and vo~ge
gradients. Electrophoresis at 4'C at 25 W for 4 - 5 hours,
without glycerol, gave the best result. Additional mobility
shifts were detected in this group of samples with this
procedure. Therefore, by using a combination of ~ese two
procedures, mutations in rpoB could be detected In ~95%
of the AMP-resistant isolates tested by SSCP anaiysls.
Statistical analysis
Most MDA M, tuberculosis isolates are resistant to
rifampicin. All the isolates (N = 120) used in this study were
either resistant to one (AMP) or more antibiotics. Statistical
ana/lysis of the proportions was done under a binomial
distribution curve, using a scientific table for statistical
values in a population." This analysis showed that ail (100%)
of the AMP-resistant isolates were resistant to INH and 10%
were also resistant to streptomycin (SM). Much lower
percentages for the other antibiotics (6%, 6%, 4% and
1.5%) were obtained for cycloserine (Cyclo), kanamycin
(Kanam), ethambutol (EMS) and thiacetazone [Thlacet)
respectively. P-values were calculated and occurred ..
between 96.97 and 100 for 95% and 99% confidence limits
respectively for INH resistance. For the other antibiotics, the
P-values were not significant.
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Fig. 1. Mutations in the tpOB gene 01 M. tuberculosis. SSCP analysis
was done using a 'standard set' 01 conditions as described under
'Materials and methods'. Lanes 1 to 9 represent PeR amplification
product 01 cultures 01 RMP-resistant clinical isolates, and the
control strain H»Rv in lane 1O. The molecular weight marker,
eX1741HaelIJ was used, although not indicated in this figure.
Detection of mutations directly from
BACTEC cultures
Previous reports, including the mutational analyses
described above, have so far made use of pure cuttures or
sub-cultures for amplification of the M. tuberculosis genes.
Implementation of a combination of a standard culturing
method together with a molecular technique was attempted
for shortened screening for drug resistance of M.
tubercu/osis-containing clinical samples.
The resuits indicated that amplification of the rpoB gene
fragment could be obtained from BACTEC cuttures with Gls
'" 100, which were obtained on day 1 (Rg. 2). Once pos~ive
amplification could be obtained, SSCP analysis was
possible. Aesu~ showed that even at a dilution of 1:16, a
mobility shift was visible (lane 7, Rg. 2). This resutt indicated
that ~ is possible to detect rpoB gene mutations by the
SSCP procedure directly from cultures in BACTEC medium
~er a relatively short culture period.
Direct detection of mutations from
sputum samples
Four ZN-positive sputum samples were used. Templates for
the amplification of a fragment of the kafG gene, including
codon 463,' were prepaned by a sucrose method described
previously.12 Positive amplification was possible using these
isolates, after which SSCP analysis was done. The resu~
(Rg. 3) showed that PCA-SSCP analysis can be done
directly from raw sputum samples, free from PCA
amplification inhibitors and without prior DNA purification.
No band mobility shifts were detected for these particular
samples with SSCP analysis, companed to the control H~Rv.
SAMJ Volumt 86 No. 1 January 1996 _
1 2 3 4 5 6 7 1 2 3 4 5 6
Discussion
Fig. 2. Early detection of mutations in the rpoB gene 'of M.
tuberculosis, obtained from peR amplification products after short
growth (1 day) in BACTEC culture medium. A RMP resistant strain,
TB0287193, previously shown to contain a mutation in this gene. was
used. lane 1: control strain H'JI'Rv, lane 2: TB0287/93, lanes 3 - 7:
dilutions in different ratios of the control and resistant isolates (1:1,
2:1,4:1,8:1, and 16:1, respectively). oX174/Hae/ll was used as
molecular weight marker (not shown).
The use of conventional cUlturing methods in the diagnosis
and susceptibility testing of clinical isolates of M.
tuberculosis is protracted, and can take up to 12 weeks
before a prediction of a resistance pattern can be made.
This has negative consequences for the treatment of
infected individuals, and can contribute towards spread of
MDR organisms, Ideally. instead of culture detection for
susceptibiiity testing of tubercle bacilli. it would be more
useful to have a procedure which could shorten these
procedures. It has previously been shown that> 90% of
clinical isolates resistant to AMP have mutations in the rpoB
gene.' This allows the attractive opportunity of using this
locus as a marker for AMP resistance. However, results from
the previous studies were collectively obtained from both
SSCP analysis and sequence data, Results from this stUdy
showed that by using a combination of two optimised SSCP
procedures, it was possible to detect mutations in 95% of
20 RMP-resistant clinical isolates of M tuberculosis. It is
possible that the remaining 5% of the samples analysed. not
showing SSCP mobility shifts with any of these two
aptimised procedures, m~ht not have mutations in this
amplified region of rpoB, Alternatively. these two procedures
might not be aptimised for detection of some uncommon
mutations. Other methods, such as dideoxy-fingerprinting
(ddF)" and denaturing gradient gel electrophoresis (DDGE)."
might assist in detection of these mutations. if present.
204-+
Fig. 3. PCR amplification products of a fragment of the btG gene
from four ZN·positive sputum samples were analysed by SSCP.
Lanes 1 - 4 represent the sputum samples, and lane 5 the control
HJ7Rv. The molecular marker oX174lHaelJl can be seen in lane 6.
For diagnostic purposes rt is important to evaluate these
procedures, since automated sequencing is not economical
or practical for all institutions.
The results suggest that it is not only possible to use
mutations in the rpoB gene to predict RMP resistance, but
since there is a 95% chance that the particular organisms
are also INH-resistant. this locus (rpoB) may also be used in
the prediction of MDR strains. It was also shown in this
study that culture may be unnecessary. and that mutational
screening can be done after short cutture periods in
BACTEC medium. or even directly from sputum samples,
This may have immediate implications for the decision on
chemotherapy, It is currently not feasible to test all
tuberculosis cases. and it is recommended that only high-
risk cases be selected,
A recent survey on drug resistance in the Western Cape'6
indicated figures of 10,8% and 4,2% for acquired
resistance, and an overall incidence of 6.8% and 2.4%
(N = 7 266) for INH and RMP respectively. when both initial
and acquired resistance were taken into account. From this
it can be predicted that approximately 174 patients were
infected with MDR strains of M. tuberculosis. and the
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opportunistic infections.~Other studies have included retinal
complications,6 neurological manifestations of HIV-2 7 and the
importance of cancers, especially Kaposi's sarcoma, in HIV-
positive people.8 Serological markers of STDs have been
used to show that pregnant women with HIV-1 infection are
more likely to show evidence of STD infection than
uninfected women9 and that there is a high risk of STDs
among asymptomatic HIV-positive female blood donors.1o
Technical studies
Fig. 2. The number of articles and reviews (excluding
commentaries) published on HIV/AIDS in South Africa according
to four categories for 4-year periods.
Fig. 1. The number of articles (including reviews) and
commentaries (including editorials, letters, reports and briefings)
devoted to four main categories of work: (;) technical - including
associated diseases, assays, clinical features and diagnosis; (ill
epidemiology - including estimates of incidence and prevalence,
predictions and modelling; (Hi) social science - including
behaviour, counselling, education, knowledge; (iv) policy and
planning. Included in this breakdown are 82 refereed articles and
84 commentaries.
The fragmented nature of South African society has led to a
series of epidemics, first among the gay community, then
people suffering from haemophilia and requiring blood
products, then the urban working classes, and now those
living in rural areas.
During the latter half of the 1980s, several estimates were
made of the prevalence of HIV infection among gay men;
this was then thought to be between 10% and 15%.11
Because these mainly middle class, educated people were
affected early on and have experienced the full force of the
epidemic, they may be the one group among whom the
prevalence of HIV is no longer increasing, and the number of
AIDS cases report~ among homosexual and bisexual men
and drug users levelled off at about 40 per 6 months in
1990.12
In the early 1980s, a mini-epidemic was experienced
among haemophiliacs of whom 39 became infected with
HIV, apparently as a result of receiving American factor VIII
concentrate. 13 Subsequent blood transfusions are thought to
be safe, however, and this is not expected to present
significant risks in the future. 1.. Extensive testing has
subsequently been done on blood donors and during the
first 6 months of 1988, only 0.005% (46 people) were found
to be HIV-positive.ll While blood donors under-represent
high-risk groups, it is clear that the general level of HIV
infection was still low in the late 1980s.
Although the data are less precise for intravenous drug
users, they too showed little evidence of HIV infection in the
1980s." The first confirmed case of AIDS clearly attributable
to intravenous drug use was diagnosed in 1989.16
The advent of HIV infection in the black heterosexual
population was shown by tests of antenatal blood samples.
Between May 1987 and July 1988 infection rates were
0.10 ± 0.01 % among black people, 0.09 % (0.03 - 0.21 %)
among coloured people, 0% « 0.4%) among Indian people,
and 0% « 0.03%) among white people." (All errors are 95%
confidence limits.) In Johannesburg a survey of infection
rates in male and female STD clinic atlendees and female
family planning clinic attendees carried out in 1990, gave
prevalences of 1.8%, 2.7% and 1.1 % respectively.l1 While
the prevalences of HIV infection were considerably lower
than in equivalent populations in East Africa at that time,
there was little room for complacency.
In the mid-1980s the mining industry employed
approximately 750 000 workers, most of whom were
migrants either from rural areas within South Africa or from
neighbouring states. Because most of these men live in
single-sex hostels without wives or families, they clearly
represent a high-risk group. Two surveys were done in 1986.
The first, involving 1 200 women providing companionship
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Since the diagnosis of the first AIDS cases in South Africa2 a
number of technical studies have been carried out. These
have been concerned with the safety of blood supplies,
diseases associated with HIV infection, and clinical features
of AIDS. There has been considerable debate about the
suitability of various tests for HIV infection.3
The experience in South Africa is similar to that in most
African countries:" tuberculosis is the most common
complicating infection, followed by acute pneumonia;
Pneumocystis carinii pneumonia is rare and Herpes zoster is
often the first sign of HIV infection. Early studies showed
that South Africans with Kaposi's sarcoma do not have
significant underlying immunodeficiency or associated
Fig. 2 shows changes in the emphasis of research over
time. The number of papers devoted to technical matters
has remained steady, the number of epidemiological studies
increased after the mid-1980s but the contribution of social
science has increased dramatically over the 12-year period,
reflecting the increasing awareness that technical solutions
are unlikely to be found in the near future and that greater
emphasis needs to be placed on social issues that were
neglected in the early years of the epidemic.
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to miners working on several different gold mines, found no
cases of HIV infection.ll The second, involving mine-
workers, found that among Malawians the prevalence was
4%, among those from Botswana it was 0.3% while among
those from Lesotho, Mozambique, Swaziland and South
Africa it was less than 0.1 %.\8 Unfortunately, this very
important set of data appears never to have been fully
analysed or presented. While it led to the recommendation
~hat the mines develop a preventive educational programme,
It also led to the recommendation that since the 'prevalence
of the disease has been established [the surveillance
programme WOUld] be suspended for white and black
employees alike'.18 In the early stages of an epidemic of HIV
infection the dOUbling time for the incidence of HIV infection
is usually about 1 year so that 10 years is sufficient to
increase the prevalence 1 000 times. In 1986 it should have
been clear that there was a window of about 5 years during
which time effective measures would have had to be
implemented if the spread of the disease were to be
contained.
The extent of migrant labour in South Africa meant that
once HIV infection had taken hold in the urban areas it
would inev~ably spread to rural areas. In the late 1980s
prevalences among rural people were stilllow.17.Ii,20 By 1993,
however, seroprevalence among women attending antenatal
clinics in Hlabisa, Kwazulu, was 7.9 ± 2.0% with an
estimated doubling time of 16 months.21
In order to understand the current state of the epidemic
and to make reliable predictions it is essential to determine
the current prevalence, the incidence and the rate at which
the disease progresses in infected people. Experience from
other developing countries shows that once the disease is
established in a given population, the prevalence of HIV and
the incidence of AlDS increase exponentially. Later in the
epidemic, the rate of increase slows as the proportion of
susceptible people declines2Z and the epidemic changes the
demographic structure of the population.
In 1990 the doubling time of HIV prevalence was 8.5% ± 1
months among black heterosexuals, between 7 and 21
months among pregnant women at Baragwanath Hospital,
Johannesburg," and 11, 10 and 7 months among men and
women attending STD clinics and women attending
family-planning clinics, respectively.\1 In 1994, nationwide
surveys of antenatal c1inic;s2" gave prevalences ranging from
a low of about 0.7% in Venda and the Cape to 4.8% in
Kwazulu-Natal, w~h dOUbling times in all regions of
approximately 1 year.
In 1900 Schall published models" to predict the course of
the HIV epidemic over the next 30 years among men and
women aged 15 - 49 years. The prevalence of HIV infection
(Schall's scenario 2) increases exponentially In the eariy
19905, increases more slowly through the late 1990s and
reaches peak values in the region of 40 - 50% in the early
years of the next decade. Schall argues that this is a worst-
case scenario but believes that prevalences could reach
30% in the early years of the next decade. In 1993 the
prevalence of HIV rnfection among women of child-bearing
age (15 - 49 years) was estimated to be 4.7%" and the
incidence of reported AIDS cases to be 67 per million per
year, with doubling times of 14 months and 13 months
respectively. These data are consistent w~ Schall's model
for the early years of the epidemic.
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The social science papers cover a wide and fragmentary
range of topics, samples and methodologies so that only
some broad trends are outlined here. Undegger and Wood21
categorise the development of HIVlAlDS in four stages:
V) the predisposition to and risk of HIV; (il) becoming
infected with HIV; (jiI) the deVelopment of end-stage
symptoms; and Qv) AIDS-related death. Almost all the social
science papers deal with stage 1, with some notable
exceptions. Schlebusch and Cassidy2" consider the influence
of psychosocial co-factors on the course of the disease and
in particular, the importance of psychosocial stress, social '
support and emotional adjustment in the progression of the
disease while lsaacs and Pegg&" focus on psychotherapy
and discuss the value of crisis intervention as a therapeutic
approach in dealing with people w~ HIVlAIDS.
Most papers are concerned with the first of the four
stages outlined above, insofar as they deal with issues that
relate directly or indirectly to HIVlAlDS-related knOWledge,
attitudes and behaviours of various groups. These groups
can be broadly divided into: (I) people involved in
administering HIVlAIDS interventions (inclUding health
professionals in general,3O.31 social workers32.33 and teacherg34);
and (il) groups of people considered to be at risk of HIV
infection (such as school pupils and adolescents 35-31
university students,38 street children,J9 and sm ciinic
attendees4· While some studies in the second category
only measured knowledge and attitudes, others also studied
reported behaviour. The diverse range of samples and
measuring instruments makes it difficult to generalise, but
several studies have found that, despite high levels of
knOWledge about HIV/AIOS, mineworkers,.(\ street-ehildren3ll
and university students" still indulged in a range of high-risk
sexual behaviours. These findings are consistent with a
substantial social psychologicalliterature,4.2 which suggests
that changing people's knowledge and attitudes is
insufficient to change their behaviour.
The weak relationship between perceived health risk and
preventive health behaviour presents particular challenges
for social science researchers concerned with developing
predic1ive models of high-risk behaviours that go beyond
the influential but flawed knowledge-attitudes-practices
(KAP) framework, which views knowledge and attitudes as
primary determinants of behaviour. The reviewed literature
proVides some interesting starting points which highlight
other co-factors that determine unsafe sexual behaviour.
For example, Perkel et aI..t3 suggest that sexual self-concept
is a key mediator between HIVlAlDS-related knowledge and
behaviour and argue that people with a low sexual self-
concept are more likely to indulge in unsafe sex. Several
paper-s".Io5 consider socio-economic issues such as migrant
labour and commercial sex work. which both create high-
risk s~ations for contracting HIVlAlDS, but may be the only
options for people from poor communities. Others consider
the economic and cultural constraints on women that make
them parlicularly powerless In the negotiation of sexual
encounters.4&
The weak correlation between people's knowledge and
attitudes on the one hand, and behaviour on the other has
implications for the types of educational interventions tl,a1
are likely to succeed In promoting HIV/AlDS preventive
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technology described in this paper would have been helpful
in these cases. In some regions in the Western Cape, such
as the Breederivier, acquired resistance can be as high as
19.3% and in such areas application of this technology may
be particularly valuable. Patients with a history of previous
tuberculosis treatment also have an almost three times
higher risk of presenting with drug resistance, and may be
good candidates for screening.
Other groups of patients to be investigated could be HIV-
infected patients, where the chances are high for the
presence of drug-resistant isolates,17 as well as contacts of
patients with drug-resistant strains.
It is, however, important to note that there is always a
possibility for non-detection of mutations using a molecular
screening technique. Susceptibility testing can still be done
where indicated. Since molecular diagnosis of drug
resistance can decrease the time for screening for
resistance, from 6 - 12 weeks to a few days, the limited
application of this technology, as indicated, may contribute
towards combating the spread of drug-resistant strains of
M. tuberculosis.
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HIV/AIDS in South Africa
c. M. Campbell, B. G. Williams
The HIVlAIDS epidemic in South Africa is developing
approximately 10 years behind the epidemics in East and
Central Africa. In 1990 the prevalence in most groups tested
was stili low, typically less than 1%, but it was already
known that the doubling time was about 1 year and it was
clear that within the next 5 years prevaJences would reach
10 - 30% in some groups.' The years between 1990 and
1995 were a window of opportunity during which time the
control and management of HIV could have greatly reduced
the future spread of the disease. This opportunity has been
lost and prevalences in many groups have reached the
expected levels.
The most important factors leading to severe HIV
epidemics are well known and include high rates of sexually
transmitted diseases (STDs). opportunistic infections,
especially tuberculosis, and a range of social factors such
as migrancy, social and political instability, and disruption Of
social support mechanisms and family structures. tt is likely
that the prevalence of HIV and the incidence of AIDS will
continue to increase over the next 5 years. At this critical
juncture in South Africa's history we face the possibility of a
major, preventable epidemic that will decimate the
economically active population. Yet effective interventions,
through the control of STDs and effective, participatory,
community-based education programmes that promote low-
risk sexual behaviour. could have a dramatic effect on the
future course of the epidemic.
The evidence, so far, is that none of the scientific
communITy's attempted interventions has significantly
altered the course of the epidemic. In this paper we review
the scientific literature on HIV/AlDS in South Africa to
suggest areas in which more research needs to be done and
ways in which scientists can contribute to the management
of the epidemic.
In April 1995 we searched three bibliographical databases,
MEDUNE, SOCUT and PSYCHUT, for articles containing
the key-words 'AIDS' and/or 'HIV' and 'South Africa', and
followed up references cited in the papers that were found.
(Because of space constraints it has not been possible to
cite all of the papers that were reviewed.) Fig. 1 shows the
number of publications concerned with technical issues.
epidemiology, social science, and policy and planning. Each
category has received a similar amount of attention but
social science studies appear mainly as full papers while
policy issues have been debated largely in the 'letters'
columns.
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